Literature DB >> 10372458

[Potential impact of measures to minimize drug costs in Aragon's primary care system].

M Siles Gutiérrez1, F J García Latorre, J M Abad Díez, E Bazo Fernández, Y Camarena Fuertes, F Muñoz Espílez.   

Abstract

OBJECTIVE: To analyse the potential saving in pharmaceutical expenditure which the use of drug products of the same composition and lower price would suppose, by three high-consumption therapeutic sub-groups.
DESIGN: Retrospective observation study.
SETTING: Primary care. PARTICIPANTS: All the medical prescriptions of the doctors in the 121 primary care health districts in the three provinces of the Autonomous Community of Aragon during 1997, divided into the sub-groups: peptic ulcer (AO2B), lipid-lowering (B04A) and hypotensor drugs (C02).
MEASUREMENTS AND MAIN RESULTS: Consumption, cost of treatment per day and potential saving of eight active principles belonging to these 3 sub-groups were calculated. Potential overall saving reached the figure of 972 million pesetas in Aragon in 1997.
CONCLUSIONS: The alternative of prescribing drugs with an identical composition and lower price offers great potential savings in pharmaceutical expenditure, and may be a useful measure to improve the efficiency of health resources, and in particular those devoted to drug prescription.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10372458

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  1 in total

1.  [Generic drugs in Spain: first stage].

Authors:  M Siles Gutiérrez; M Goldaracena Tanco
Journal:  Aten Primaria       Date:  2000 Jul-Aug       Impact factor: 1.137

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.